国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (21): 2969-2973.DOI: 10.3760/cma.j.issn.1007-1245.2022.21.003

• 专题:脑血管疾病研究 • 上一篇    下一篇

急性缺血性卒中患者血管内治疗疗效的相关因素分析

李明月1,2  李自如2  姚远2,3  袁军2   

  1. 1内蒙古医科大学内蒙古临床医学院,呼和浩特 010017;2内蒙古自治区人民医院神经内科,呼和浩特 010017;3内蒙古大学生命科学学院,呼和浩特 010070
  • 收稿日期:2022-07-19 出版日期:2022-11-01 发布日期:2022-11-16
  • 通讯作者: 袁军,Email:13947108585@139.com
  • 基金资助:
    2022年度内蒙古自治区卫生健康科技计划项目(202201043)

Factors related to efficacy of endovascular therapy for patients with acute ischemic stroke

Li Mingyue1,2, Li Ziru2, Yao Yuan2,3, Yuan Jun2   

  1. 1 Inner Mongolia Clinical Medical College, Inner Mongolia Medical University, Hohhot 010017, China; 2 Department of Neurology, Inner Mongolia People's Hospital, Hohhot 010017, China; 3 School of Life Sciences, Inner Mongolia University, Hohhot 010070, China
  • Received:2022-07-19 Online:2022-11-01 Published:2022-11-16
  • Contact: Yuan Jun, Email: 13947108585@139.com
  • Supported by:
    Project of Plan of Health Science and Technology in Inner Mongolian Autonomous Region in 2022 (202201043)

摘要: 随着2015年5项随机对照临床试验陆续发表,血管内治疗已成为大动脉闭塞所致急性脑梗死患者优选治疗方案。有一部分患者尽管血管已经再通,但是其预后不良。笔者通过查阅相关资料,发现有很多因素可能会影响到血管再通的效果及预后。该文就从时间窗、高血糖、侧支循环、血压、取栓次数、美国国立卫生研究院卒中量表(NIHSS)评分等部分影响血管内治疗疗效的可能因素作一综述。

关键词: 急性缺血性卒中, 血管内治疗, 疗效, 相关因素

Abstract: With the publication of five randomized controlled clinical trials in 2015, endovascular therapy has become the preferred treatment for patients with acute cerebral infarction caused by large artery occlusion. Some patients have poor prognosis despite recanalization. By consulting relevant data, the author found that there were many factors that may affect the effect and prognosis of recanalization. This article reviews the possible factors affecting the efficacy of endovascular therapy, including time window, hyperglycemia, collateral circulation, blood pressure, number of thrombectomy, and National Institutes of Health Stroke Scale (NIHSS) score.

Key words: Acute ischemic stroke, Endovascular therapy, Curative effect, Related factors